financetom
Business
financetom
/
Business
/
US FDA approves AbbVie's treatment for intra-abdominal infections
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves AbbVie's treatment for intra-abdominal infections
Feb 7, 2025 10:58 AM

Feb 7 (Reuters) - AbbVie ( ABBV ) said that the U.S.

Food and Drug Administration approved its drug for complicated

intra-abdominal infections on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved